The store will not work correctly when cookies are disabled.
10H-indeno[1,2-b]pyrido[3,4-e]pyrazin-10-one oxime
ID: ALA4514173
PubChem CID: 155539342
Max Phase: Preclinical
Molecular Formula: C14H8N4O
Molecular Weight: 248.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O/N=C1/c2ccccc2-c2nc3ccncc3nc21
Standard InChI: InChI=1S/C14H8N4O/c19-18-13-9-4-2-1-3-8(9)12-14(13)17-11-7-15-6-5-10(11)16-12/h1-7,19H/b18-13-
Standard InChI Key: DGYKSZOQVJDTRZ-AQTBWJFISA-N
Molfile:
RDKit 2D
19 22 0 0 0 0 0 0 0 0999 V2000
15.9421 -3.7062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9409 -4.5258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.6490 -4.9347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6472 -3.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3558 -3.7026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3566 -4.5216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0651 -4.9287 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.0595 -3.2924 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7686 -3.6957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7762 -4.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5576 -4.7607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5453 -3.4355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0307 -4.0938 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8416 -4.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.1681 -3.2520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6776 -2.5936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8684 -2.6889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8181 -5.5353 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2776 -6.1481 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 13 1 0
12 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 2 0
18 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 248.25 | Molecular Weight (Monoisotopic): 248.0698 | AlogP: 2.23 | #Rotatable Bonds: ┄ |
Polar Surface Area: 71.26 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.22 | CX Basic pKa: 3.15 | CX LogP: 2.00 | CX LogD: 1.60 |
Aromatic Rings: 3 | Heavy Atoms: 19 | QED Weighted: 0.38 | Np Likeness Score: -0.45 |
References
1. Schepetkin IA, Khlebnikov AI, Potapov AS, Kovrizhina AR, Matveevskaya VV, Belyanin ML, Atochin DN, Zanoza SO, Gaidarzhy NM, Lyakhov SA, Kirpotina LN, Quinn MT.. (2019) Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors., 161 [PMID:30347329] [10.1016/j.ejmech.2018.10.023] |